Form 8-K - Current report:
SEC Accession No. 0000950170-23-020786
Filing Date
2023-05-11
Accepted
2023-05-11 06:20:49
Documents
16
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-20230511.htm   iXBRL 8-K 58907
2 EX-99.1 sybx-ex99_1.htm EX-99 37669
3 GRAPHIC img56602281_0.jpg GRAPHIC 135541
4 GRAPHIC img56602281_1.jpg GRAPHIC 30049
5 GRAPHIC img56602281_2.jpg GRAPHIC 35314
  Complete submission text file 0000950170-23-020786.txt   499479

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sybx-20230511.xsd EX-101.SCH 2480
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sybx-20230511_lab.xml EX-101.LAB 19075
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sybx-20230511_pre.xml EX-101.PRE 12004
10 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20230511_htm.xml XML 4872
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 23908685
SIC: 2834 Pharmaceutical Preparations